
Heska Corporation HSKA
Quarterly report 2023-Q1
added 05-05-2023
Heska Corporation Operating Cash Flow 2011-2026 | HSKA
Annual Operating Cash Flow Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21.8 M | 6.25 M | -656 K | 3.3 M | 13.3 M | 10.4 M | 5.86 M | 2.12 M | 5.55 M | -1.41 M | -369 K | 4.89 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | -21.8 M | 2.28 M |
Quarterly Operating Cash Flow Heska Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.16 M | - | -18.7 M | -16.6 M | -17.7 M | - | 5.27 M | 7.15 M | 1.34 M | - | -8.1 M | -13.1 M | -4.76 M | - | -3.28 M | -5.36 M | 727 K | - | 6.46 M | 4.5 M | 4.21 M | - | 6.28 M | 4.86 M | 1.93 M | - | 1.88 M | 278 K | -637 K | - | -932 K | -282 K | -1.39 M | - | 3.6 M | 3.16 M | 5.22 M | - | -1.26 M | -1.06 M | 510 K | - | 1.02 M | 2.07 M | -255 K | - | 5.62 M | 3.57 M | -151 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.15 M | -18.7 M | -892 K |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 121.25 | 2.54 % | $ 36.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 21.33 | -5.2 % | $ 230 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 22.09 | -1.47 % | $ 1.18 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.52 | 4.12 % | $ 2.02 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 25.08 | 2.13 % | $ 697 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 183.47 | 3.69 % | $ 9.09 B | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 195.86 | 1.07 % | $ 140 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
713 M | $ 519.83 | 0.81 % | $ 15 B | ||
|
Illumina
ILMN
|
837 M | $ 134.35 | 1.23 % | $ 21.4 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 5.19 | 3.7 % | $ 481 M | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.38 | 2.63 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.64 | 4.33 % | $ 2.09 B | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 16.34 | 1.3 % | $ 494 M | ||
|
Precipio
PRPO
|
685 K | $ 28.81 | -0.66 % | $ 46.2 M | ||
|
Guardant Health
GH
|
-185 M | $ 90.83 | 5.99 % | $ 11.4 B | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.83 | - | $ 91.8 K | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.18 | -0.91 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 119.42 | 3.32 % | $ 9.85 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 273.05 | 2.51 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 6.8 | 0.44 % | $ 284 M | ||
|
Celcuity
CELC
|
-153 M | $ 123.43 | -1.45 % | $ 5.77 B | ||
|
Soleno Therapeutics
SLNO
|
46.8 M | $ 52.67 | 0.18 % | $ 2.68 B | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 84.14 | 0.26 % | $ 5.68 B | ||
|
Neuronetics
STIM
|
-20.4 M | $ 1.44 | 2.86 % | $ 95 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.61 | 2.17 % | $ 21.7 B | ||
|
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 6.01 | 16.27 % | $ 4.73 M | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 526.97 | 2.13 % | $ 199 B | ||
|
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.68 | -2.63 % | $ 61.9 M |